Bioline Rx Free Cash Flow TTM:
-22.10M for March 31, 2013Bioline Rx Historical Free Cash Flow TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -22.10M |
| Dec. 31, 2012 | -20.37M |
| Sept. 30, 2012 | -17.67M |
| June 30, 2012 | -14.50M |
| March 31, 2012 | -12.61M |
| Dec. 31, 2011 | -11.52M |
About Free Cash Flow (TTM)
BLRX Free Cash Flow TTM Benchmarks
| Companies | |
|---|---|
| Oramed Pharmaceuticals | -3.272M |
| Achillion Pharmaceuticals | -48.70M |
| Shire | 1.111B |
BLRX Free Cash Flow TTM Rankings
| Overall |
46th percentile 4095 of 7593 |
| Sector |
27th percentile 470 of 650 in Healthcare |
| Industry |
44th percentile 131 of 237 in Biotechnology |
BLRX Free Cash Flow TTM Range, Past 5 Years
| Minimum | -22.10M | Mar 2013 |
| Maximum | -11.52M | Dec 2011 |
| Average | -16.46M |
BLRX News
BioLineRx (BLRX) Enrolls First Patients in BL-8020 Phase I/II as HCV Treatment
Street Insider Apr 29
Street Insider Apr 29